Unrecognized diabetes mellitus among acute coronary syndrome patients in Basra, Iraq – A cross-sectional study
Więcej
Ukryj
1
Basrah Health Directorate, Basra, Iraq
2
Basra Specialized Cardiac Center, Basra, Iraq
3
Department of Family and Community Medicine, College of Medicine, University of Basrah, Iraq
Autor do korespondencji
Aya A. Al-Rubaye
Department of Family and Community Medicine, College of Medicine, University of Basrah, Al-Wefood St., Al Bradheia
Ann. Acad. Med. Siles. 2025;79:323-330
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Introduction:
Diabetes mellitus (DM) is one of the most prevalent modifiable risk factors for acute coronary syndrome (ACS). Patients with DM constitute approximately 25%–30% of those admitted with ACS. However, data on the prevalence of unrecognized DM among patients with ACS in Iraq is generally limited.
Material and methods:
This cross-sectional study was conducted on patients admitted with ACS to Al Sadir Teaching Hospital, Basra Teaching Hospital, and Basra Specialized Cardiac Center in Basra. Patients with known diabetes or conditions affecting glucose or hemoglobin A1c (HbA1c) levels were excluded. This was a consecutive sampling of eligible patients. All patients admitted during the study period who met the inclusion criteria were approached and invited to participate. Those who consented were enrolled until the desired sample size was achieved. Data were collected through direct interviews and a structured questionnaire, with anthropometric measurements and laboratory investigations, including fasting blood sugar (FBS), random blood sugar (RBS), HbA1c, and lipid profile. Patients were classified as normal, prediabetes, or newly diagnosed diabetes.
Results:
A total of 275 ACS patients were included (mean age: 56.6 ± 12.5 years; 72% male). Screening revealed that 15.3% had unrecognized diabetes and 11.6% had prediabetes. Newly diagnosed diabetes was significantly associated with younger age (P = 0.007), smoking (P = 0.013), higher BMI (P = 0.01), dyslipidemia (P = 0.001), family history of diabetes (P < 0.001), and STEMI presentation (P = 0.047).
Conclusions:
Unrecognized DM causes a significant burden among ACS patients. Effective screening for DM would aid in early detection and proper management, particularly among younger ACS patients, those with a family history of DM, smokers, and obese patients.
REFERENCJE (32)
2.
Nohria R., Viera A.J. Acute coronary syndrome: diagnosis and initial management. Am. Fam. Physician. 2024; 109(1): 34–42.
3.
Mohammad A.M., Jehangeer H.I., Shaikhow S.K. Prevalence and risk factors of premature coronary artery disease in patients undergoing coronary angiography in Kurdistan, Iraq. BMC Cardiovasc. Disord. 2015; 15: 155, doi: 10.1186/s12872-015-0145-7.
4.
Banday M.Z., Sameer A.S., Nissar S. Pathophysiology of diabetes: An overview. Avicenna J. Med. 2020; 10(4): 174–188, doi: 10.4103/ajm.ajm_53_20.
5.
Tinajero M.G., Malik V.S. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol. Metab. Clin. North Am. 2021; 50(3): 337–355, doi: 10.1016/j.ecl.2021.05.013.
6.
Abusaib M., Ahmed M., Nwayyir H.A., Alidrisi H.A., Al-Abbood M., Al-Bayati A. et al. Iraqi experts consensus on the management of type 2 diabetes/prediabetes in adults. Clin. Med. Insights Endocrinol. Diabetes 2020; 13: 1179551420942232, doi: 10.1177/1179551420942232.
7.
Mansour A.A., Al-Maliky A.A., Kasem B., Jabar A., Mosbeh K.A. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes Metab. Syndr. Obes. 2014; 7: 139–144, doi: 10.2147/DMSO.S59652.
8.
Ogurtsova K., Guariguata L., Barengo N.C., Ruiz P.L., Sacre J.W., Karuranga S. et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res. Clin. Pract. 2022; 183: 109118, doi: 10.1016/j.diabres.2021.109118.
9.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes–2020. Diabetes Care 2020; 43(Suppl 1): S14–S31, doi: 10.2337/dc20-S002.
10.
Behl T., Sehgal A., Grover M., Singh S., Sharma N., Bhatia S. et al. Uncurtaining the pivotal role of ABC transporters in diabetes mellitus. Environ. Sci. Pollut. Res. Int. 2021; 28(31): 41533–41551, doi: 10.1007/s11356-021-14675-y.
11.
Babes E.E., Bustea C., Behl T., Abdel-Daim M.M., Nechifor A.C., Stoicescu M. et al. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy. Biomed. Pharmacother. 2022; 148: 112772, doi: 10.1016/j.biopha.2022.112772.
12.
Aronson D., Edelman E.R. Coronary artery disease and diabetes mellitus. Cardiol. Clin. 2014; 32(3): 439–455, doi: 10.1016/j.ccl.2014.04.001.
13.
Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc. Diabetol. 2018; 17(1): 83, doi: 10.1186/s12933-018-0728-6.
14.
Abdullatef W.K., Al-Aqeedi R.F., Dabdoob W., Hajar H.A., Bener A., Gehani A.A. Prevalence of unrecognized diabetes mellitus in patients admitted with acute coronary syndrome. Angiology 2013; 64(1): 26–30, doi: 10.1177/0003319711434054.
15.
Nuttall F.Q. Body mass index: obesity, BMI, and health: A critical review. Nutr. Today 2015; 50(3): 117–128, doi: 10.1097/NT.0000000000000092.
17.
Mahmoodi M.R., Baneshi M.R., Rastegari A. Comparison of conventional risk factors in middle-aged versus elderly diabetic and nondiabetic patients with myocardial infarction: prediction with decision-analytic model. Ther. Adv. Endocrinol. Metab. 2015; 6(6): 258–266, doi: 10.1177/2042018815600641.
18.
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387(10027): 1513–1530, doi: 10.1016/S0140-6736(16)00618-8.
19.
Ashraf M., Sharma S., Rashid A., Ismail M., Tanvir M., Sharma P. et al. Prevalence of undiagnosed diabetes mellitus in acute coronary syndrome patients: A hospital-based study. Int. J. Sci. Study 2016; 4(2): 179–184, doi: 10.17354/ijss/2016/280.
20.
Kamceva G., Vavlukis M., Kitanoski D., Kedev S. Newly diagnosed diabetes and stress glycaemia and its’ association with acute coronary syndrome. Open Access Maced. J. Med. Sci. 2015; 3(4): 607–612, doi: 10.3889/oamjms.2015.103.
21.
Kazim A.H., Shahzad M., Rasheed S., Bilal A., Sadiq N., Sadiq T. Undiagnosed diabetes mellitus in acute coronary syndrome (ACS) patients. Pak. J. Med. Health Sci. 2022; 16(09): 365, doi: 10.53350/pjmhs22169365.
22.
Kumar N., Verma R., Chouhan B., Goyal P. Study of prevalence of undiagnosed diabetes mellitus in patients presenting with acute coronary syndrome. J. Assoc. Phys. India 2022; 70(4): 11–12.
23.
AbuShady M.M., Mohamady Y., Enany B., Nammas W. Prevalence of prediabetes in patients with acute coronary syndrome: impact on in-hospital outcomes. Intern. Med. J. 2015; 45(2): 183–188, doi: 10.1111/imj.12651.
24.
Muhammad S.S., Zaheer R., Khan S., Masood R., Sawlani A., Khan R.A. Prevalence of undiagnosed diabetes mellitus in acute coronary syndrome (ACS) patients. J. Popul. Ther. Clin. Pharmacol. 2024; 31(5): 1643–1649, doi: 10.53555/jptcp.v31i5.6399.
25.
Khan Q.A., Kiani A.H., Ahmed N., Munir T.A., Ilyas N., Tahir M.A. To assess the prevalence of undiagnosed type 2 diabetes mellitus in patients with acute coronary syndrome. Profes. Med J. 2024; 31(03): 351–356, doi: 10.29309/TPMJ/2024.31.03.7941.
26.
Poznyak A., Grechko A.V., Poggio P., Myasoedova V.A., Alfieri V., Orekhov A.N. The diabetes mellitus-atherosclerosis connection: The role of lipid and glucose metabolism and chronic inflammation. Int. J. Mol. Sci. 2020; 21(5): 1835, doi: 10.3390/ijms21051835.
27.
Filisa-Kaphamtengo F., Ngoma J., Mukhula V., Matemvu Z., Kapute D., Banda P. et al. Prevalence, patterns and associated risk factors for dyslipidaemia among individuals attending the diabetes clinic at a tertiary hospital in Central Malawi. BMC Cardiovasc. Disord. 2023; 23(1): 548, doi: 10.1186/s12872-023-03589-x.
28.
Yadegar A., Mohammadi F., Rabizadeh S., Qahremani R., Esteghamati A., Nakhjavani M. Prevalence of different patterns of dyslipidemia in patients with type 2 diabetes in an Iranian population. Transl. Med. Commun. 2022; 7: 23, doi: 10.1186/s41231-022-00129-1.
29.
Fontes-Carvalho R., Pimenta J., Bettencourt P., Leite-Moreira A., Azevedo A. Association between plasma leptin and adiponectin levels and diastolic function in the general population. Expert Opin. Ther. Targets 2015; 19(10): 1283–1291, doi: 10.1517/14728222.2015.1019468.
30.
DeForest N., Majithia A.R. Genetics of type 2 diabetes: implications from large-scale studies. Curr. Diab. Rep. 2022; 22(5): 227–235, doi: 10.1007/s11892-022-01462-3.
31.
Zhou M., Liu J., Hao Y., Liu J., Huo Y., Smith S.C. Jr. et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc. Diabetol. 2018; 17(1): 147, doi: 10.1186/s12933-018-0793-x.
32.
Authors/Task Force Members; Rydén L., Grant P.J., Anker S.D., Berne C., Cosentino F. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2013; 34(39): 3035–3087, doi: 10.1093/eurheartj/eht108.